Skip to main content
Top
Published in:

Open Access 21-03-2025 | Systemic Lupus Erythematosus | Case report

Bilateral retinal vasculitis presenting as the first manifestation of systemic lupus erythematosus: a case report

Authors: Chirath Priyanga Madurapperuma, Thuvarakan Poobalasingam, Melina Dissanayake, Supul Banagala, Sivatharsini Nagarajah, Bhatiya Premaratne, Keembiyage Ranasiri Dayawansa, Monika De Silva, Harindra Karunatilake

Published in: Journal of Medical Case Reports | Issue 1/2025

Login to get access

Abstract

Background

Systemic lupus erythematosus is a chronic autoimmune multisystemic disease in which ocular manifestations occur in up to one-third of patients. Although retinal vasculitis is a recognized feature of systemic lupus erythematosus, it is extremely rare to present as the first manifestation. This report describes a rare case of systemic lupus erythematosus, characterized by bilateral retinal vasculitis presenting as the first manifestation, which was subsequently complicated by lupus nephritis.

Case presentation

We report the case of a 32-year-old female patient from Sri Lanka who presented with progressive visual impairment, followed by fatigue, malaise, and arthralgia. She was initially diagnosed with retinal vasculitis. Later, she developed constitutional symptoms followed by mucocutaneous and renal manifestations consistent with systemic lupus erythematosus. Laboratory findings supported the diagnosis of systemic lupus erythematosus with positive antinuclear antibody and anti-double stranded DNA, as well as low complement levels. Renal biopsy confirmed class III lupus nephritis. The patient received treatment with corticosteroids, mycophenolate mofetil, and hydroxychloroquine, which resulted in significant improvements in visual, renal, and other clinical symptoms.

Conclusion

It is important to consider systemic lupus erythematosus in the differential diagnosis of isolated retinal vasculitis, even in the absence of its classic symptoms. Early identification through improved diagnostic tools and revised criteria could facilitate timely intervention and improve patient outcomes.
Literature
1.
go back to reference Parodis I, Gomez A, Tsoi A, Chow JW, Pezzella D, Girard C, et al. Systematic literature review informing the EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis. RMD Open. 2023;9:e003297.CrossRefPubMedPubMedCentral Parodis I, Gomez A, Tsoi A, Chow JW, Pezzella D, Girard C, et al. Systematic literature review informing the EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis. RMD Open. 2023;9:e003297.CrossRefPubMedPubMedCentral
2.
go back to reference Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2:16039.CrossRefPubMed Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2:16039.CrossRefPubMed
3.
go back to reference Palejwala NV, Walia HS, Yeh S. Ocular manifestations of systemic lupus erythematosus: a review of the literature. Autoimmune Dis. 2012;2012:290898.PubMedPubMedCentral Palejwala NV, Walia HS, Yeh S. Ocular manifestations of systemic lupus erythematosus: a review of the literature. Autoimmune Dis. 2012;2012:290898.PubMedPubMedCentral
4.
go back to reference Silpa-Archa S, Lee JJ, Foster CS. Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol. 2016;100:135–41.CrossRefPubMed Silpa-Archa S, Lee JJ, Foster CS. Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol. 2016;100:135–41.CrossRefPubMed
5.
go back to reference Stafford-Brady FJ, Urowitz MB, Gladman DD, Easterbrook M. Lupus retinopathy. Arthritis Rheum. 1988;31:1105–10.CrossRefPubMed Stafford-Brady FJ, Urowitz MB, Gladman DD, Easterbrook M. Lupus retinopathy. Arthritis Rheum. 1988;31:1105–10.CrossRefPubMed
6.
go back to reference Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League against Rheumatism/American College of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400–12.CrossRefPubMedPubMedCentral Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League against Rheumatism/American College of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400–12.CrossRefPubMedPubMedCentral
7.
go back to reference Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288–91.PubMed Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288–91.PubMed
8.
go back to reference Cunningham ET, Tabbara KF, Zierhut M. Systemic lupus erythematosus and the eye. Ocul Immunol Inflamm. 2018;26(8):1143–5.CrossRefPubMed Cunningham ET, Tabbara KF, Zierhut M. Systemic lupus erythematosus and the eye. Ocul Immunol Inflamm. 2018;26(8):1143–5.CrossRefPubMed
9.
go back to reference Sivaraj RR, Durrani OM, Denniston AK, Murray PI, Gordon C. Ocular manifestations of systemic lupus erythematosus. Rheumatology (Oxford). 2007;46(12):1757–62.CrossRefPubMed Sivaraj RR, Durrani OM, Denniston AK, Murray PI, Gordon C. Ocular manifestations of systemic lupus erythematosus. Rheumatology (Oxford). 2007;46(12):1757–62.CrossRefPubMed
10.
go back to reference Giorgi D, Pace F, Giorgi A, Bonomo L, Gabrieli CB. Retinopathy in systemic lupus erythematosus: pathogenesis and approach to therapy. Hum Immunol. 1999;60:688–96.CrossRefPubMed Giorgi D, Pace F, Giorgi A, Bonomo L, Gabrieli CB. Retinopathy in systemic lupus erythematosus: pathogenesis and approach to therapy. Hum Immunol. 1999;60:688–96.CrossRefPubMed
11.
go back to reference Montehermoso A, Cervera R, Font J, Ramos-Casals M, García-carrasco M, Formiga F, et al. Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus. Semin Arthritis Rheum. 1999;28:326–32.CrossRefPubMed Montehermoso A, Cervera R, Font J, Ramos-Casals M, García-carrasco M, Formiga F, et al. Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus. Semin Arthritis Rheum. 1999;28:326–32.CrossRefPubMed
12.
go back to reference Bashiri H, Karimi N, Mostafaei S, et al. Retinopathy in newly-diagnosed systemic lupus erythematosus: should we screen for ocular involvement? BMC Rheumatol. 2021;5:34.CrossRefPubMedPubMedCentral Bashiri H, Karimi N, Mostafaei S, et al. Retinopathy in newly-diagnosed systemic lupus erythematosus: should we screen for ocular involvement? BMC Rheumatol. 2021;5:34.CrossRefPubMedPubMedCentral
13.
go back to reference Alhassan E, Gendelman HK, Sabha MM, Hawkins-Holt M, Siaton BC. Bilateral retinal vasculitis as the first presentation of systemic lupus erythematosus. Am J Case Rep. 2021;22:e930650.CrossRefPubMedPubMedCentral Alhassan E, Gendelman HK, Sabha MM, Hawkins-Holt M, Siaton BC. Bilateral retinal vasculitis as the first presentation of systemic lupus erythematosus. Am J Case Rep. 2021;22:e930650.CrossRefPubMedPubMedCentral
14.
go back to reference Barkeh HJ, Muhaya M. Optic neuritis and retinal vasculitis as primary manifestations of systemic lupus erythematosus. Med J Malaysia. 2002;57(4):490–2.PubMed Barkeh HJ, Muhaya M. Optic neuritis and retinal vasculitis as primary manifestations of systemic lupus erythematosus. Med J Malaysia. 2002;57(4):490–2.PubMed
15.
go back to reference Palkar AH, Hossain MD, Majumder PD. Purtscher-like retinopathy a presenting manifestation of systemic lupus erythematosus following high-grade fever with myalgia and arthralgia. Indian J Ophthalmol. 2018;66(9):1317–9.CrossRefPubMedPubMedCentral Palkar AH, Hossain MD, Majumder PD. Purtscher-like retinopathy a presenting manifestation of systemic lupus erythematosus following high-grade fever with myalgia and arthralgia. Indian J Ophthalmol. 2018;66(9):1317–9.CrossRefPubMedPubMedCentral
16.
go back to reference Bandyopadhyay SK, Moulick A, Dutta A. Retinal vasculitis – An initial presentation of systemic lupus erythematosus. J Indian Med Assoc. 2006;104(9):526–7.PubMed Bandyopadhyay SK, Moulick A, Dutta A. Retinal vasculitis – An initial presentation of systemic lupus erythematosus. J Indian Med Assoc. 2006;104(9):526–7.PubMed
17.
go back to reference Aldhefeery N, Alhadhood N, Alkadi A. Bilateral retinal vasculitis as initial presentation of systemic lupus erythematosus with secondary antiphospholipid syndrome. Am J Case Rep. 2023;28(24):e942085. Aldhefeery N, Alhadhood N, Alkadi A. Bilateral retinal vasculitis as initial presentation of systemic lupus erythematosus with secondary antiphospholipid syndrome. Am J Case Rep. 2023;28(24):e942085.
18.
go back to reference Donnithorne KJ, Read RW, Lowe R, Weiser P, Cron RQ, Beukelman T. Retinal vasculitis in two pediatric patients with systemic lupus erythematosus: a case report. Pediatr Rheumatol Online J. 2013;11(1):25.CrossRefPubMedPubMedCentral Donnithorne KJ, Read RW, Lowe R, Weiser P, Cron RQ, Beukelman T. Retinal vasculitis in two pediatric patients with systemic lupus erythematosus: a case report. Pediatr Rheumatol Online J. 2013;11(1):25.CrossRefPubMedPubMedCentral
19.
go back to reference Ushiyama O, Ushiyama K, Koarada S, Tada Y, Suzuki N, Ohta A, et al. Retinal disease in patients with systemic lupus erythematosus. Ann Rheum Dis. 2000;59(9):705–8.CrossRefPubMedPubMedCentral Ushiyama O, Ushiyama K, Koarada S, Tada Y, Suzuki N, Ohta A, et al. Retinal disease in patients with systemic lupus erythematosus. Ann Rheum Dis. 2000;59(9):705–8.CrossRefPubMedPubMedCentral
20.
go back to reference Jabs DA, Fine SL, Hochberg MC, Newman SA, Heiner GG, Stevens MB. Severe retinal vaso-occlusive disease in systemic lupus erythematosus. Arch Ophthalmol. 1986;104(4):558–63.CrossRefPubMed Jabs DA, Fine SL, Hochberg MC, Newman SA, Heiner GG, Stevens MB. Severe retinal vaso-occlusive disease in systemic lupus erythematosus. Arch Ophthalmol. 1986;104(4):558–63.CrossRefPubMed
21.
go back to reference Seth G, Chengappa KG, Misra DP, Babu R, Belani P, Shanoj KC, et al. Lupus retinopathy: a marker of active systemic lupus erythematosus. Rheumatol Int. 2018;38:1495–501.CrossRefPubMed Seth G, Chengappa KG, Misra DP, Babu R, Belani P, Shanoj KC, et al. Lupus retinopathy: a marker of active systemic lupus erythematosus. Rheumatol Int. 2018;38:1495–501.CrossRefPubMed
22.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO) Lupus Nephritis Work Group. KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS. Kidney Int. 2024;105(1S):S1–69. Kidney Disease: Improving Global Outcomes (KDIGO) Lupus Nephritis Work Group. KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS. Kidney Int. 2024;105(1S):S1–69.
Metadata
Title
Bilateral retinal vasculitis presenting as the first manifestation of systemic lupus erythematosus: a case report
Authors
Chirath Priyanga Madurapperuma
Thuvarakan Poobalasingam
Melina Dissanayake
Supul Banagala
Sivatharsini Nagarajah
Bhatiya Premaratne
Keembiyage Ranasiri Dayawansa
Monika De Silva
Harindra Karunatilake
Publication date
21-03-2025
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2025
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-025-05158-6

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more